---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "YOOK2nFgMlNK+r9nQgTzpA3s5RcMFNt4PCQADPHyWoZXbyDcNRZnO6okDjgeFDjo7qyrK/DquMGoE329pmhk2DQt7jBvP/kQjzoqKtWh1C7NteEJdBSh02F9B1OPOinIvFLMOLAFbKT+UaEfpfTVdeKJDjJRIJgrxYOD84KJ2fxk/PuO4io9uLcsOTqOR/LzrfCX8TwJB9IDRMi3YiLTz1qtb3mtOVoJv8i2OnXs2evRKi5UG9lR9XAYOW3EL11HQc1/9VZ+wNW99PEE8tiZhiJ0wLPUnyETpnkP/7CUpoOvZjSG5TwBojAxf/CniX+i;Ncy+o/XgYFpbBqkcT574PA=="
---

